CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of ...

Could a new device called a portable neuromodulation stimulator (PoNS) help improve your mobility and balance with multiple sclerosis? PoNS is a device that delivers mild electrical pulses to two ...

Helius Medical Technologies (NASDAQ:HSDT) shares are trading higher Wednesday after the company announced an authorized claim ...

Helius Medical Technologies will present significant new study results at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting, showcasing the sustained efficacy of its PoNS® device.

This figure reflects the typical adjusted price for out-of-network claims and represents an important validation of both the clinical need and the overall value of the PoNS Device. A Breakthrough ...

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

This marks the fifth major commercial healthcare payer to authorize claims for the PoNS device, following a recent similar authorization by Anthem MultiPlan at a negotiated price of $19,160.

PoNS® devices to be provided to a least five sites in five separate administrative regions within Québec---- Government-funded initiative will evaluate the benefits of PoNS Therapy™ when used ...

CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan ...